Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 18/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5068419 | 0.79 | CYP2D6 (0.44) | — | |
| SCHEMBL17422956 | 0.79 | CYP2D6 (0.44) | — | |
| SCHEMBL2712123 | 0.76 | DPP4 (0.60) | DPP4 | |
| SCHEMBL2492730 | 0.75 | CHRNB2 (0.34) | — | |
| SCHEMBL2496516 | 0.74 | DPP4 (0.35) | DPP4 | |
| SCHEMBL2497616 | 0.74 | DPP4 (0.35) | DPP4 | |
| SCHEMBL2494836 | 0.74 | DPP4 (0.35) | DPP4 | |
| SCHEMBL2493614 | 0.74 | DPP4 (0.35) | DPP4 | |
| Trifluoroacetic Acid SCHEMBL2500245 | 0.74 | HDAC2 (0.46) | HRH3HDAC2DPP4 | |
| Trifluoroacetic Acid SCHEMBL2495000 | 0.74 | HDAC2 (0.46) | HRH3KCNH2HDAC2DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030499-B2 | 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| US-20080318923-A1 | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318923-A1 | 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle | AVPR1B, AVPR1A, AVPR2 | HRH3 18/4885KCNH2 1200/4885HDAC2 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.